<DOC>
	<DOCNO>NCT01518829</DOCNO>
	<brief_summary>value serum procalcitonin differentiation bacterial infection non infectious inflammation febrile HCC patient follow locoeregional treatment HCC .</brief_summary>
	<brief_title>Procalcitonin Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Hepatocellular carcinoma patient undergo TACE and/or radiofrequency . 2 . Fever 38C 48 hour post intervention . 1 . HCC Patients develop fever intervention . 2 . Proven infection elsewhere ( e.g . UTI , chest infection.. )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>hepatocellular carcinom</keyword>
	<keyword>postablation syndrom</keyword>
	<keyword>procalcitonin</keyword>
</DOC>